What is IVF stock price today?

IVF (Invo Fertility Inc) stock is trading at $2.21 as of the latest market data. Stock prices update in real-time during market hours (9:30 AM - 4:00 PM ET).

Is IVF stock going up or down today?

IVF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy IVF stock now?

The decision to buy IVF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is IVF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for IVF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is IVF stock overvalued or undervalued?

Use our DCF valuation calculator to determine if IVF is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is IVF's P/E ratio?

P/E ratio data for IVF will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is IVF's market cap?

IVF (Invo Fertility Inc) has a market capitalization of $0.02 billion, making it a small-cap stock.

What is IVF's price to book ratio?

IVF trades at a price-to-book (P/B) ratio of 5.97, which compares the stock price to the company's book value per share. A P/B below 1.0 may indicate undervaluation, while above 3.0 may suggest premium pricing.

Does IVF pay dividends?

IVF does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is IVF's dividend yield?

IVF does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is IVF stock a good long-term investment?

IVF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is IVF's revenue growth rate?

IVF has shown revenue growth of 0.2% over recent periods. Consistent revenue growth is a key indicator of business health and competitive positioning.

Profitability metrics for IVF are available on our dashboard with complete income statement analysis.

What are the risks of investing in IVF?

Key risks for IVF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does IVF compare to its competitors?

Compare IVF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize IVF's performance and positioning.

What is IVF's stock price target for 2026?

Our AI model provides price targets for IVF based on fundamental analysis: Bull case $2.87 (+30%), Base case $2.54 (+15%), Bear case $1.99 (-10%). Visit our prediction page for detailed forecasts.

What do analysts say about IVF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for IVF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is IVF's next earnings report?

IVF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

IVF - Invo Fertility Inc

NYSE * Health Care * Health Care Providers & Services

$2.21

+$0.03 (+1.38%)

About Invo Fertility Inc

INVO Fertility, Inc., a healthcare services company, focuses on the fertility marketplace that provides assisted reproductive technology care to patients. It operates through Fertility Clinic Services; INVOcell Device; and Therapeutics segments. The company offers INVOcell Device, a medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. It also operates fertility clinics, including INVO Centers. In addition, the company develops NY-303, a GPC3 x NKp46 bifunctional antibody that is in Phase i/ii a monotherapy trial for the treatment of hepatocellular carcinoma; and NY-500, an AI-optimized bifunctional antibody. The company was formerly known as NAYA Biosciences, Inc. and changed its name to INVO Fertility, Inc. in April 2025. INVO Fertility, Inc. was founded in 2007 and is based in Sarasota, Florida.

IVF Key Statistics

Market Cap

$15.18M

P/B Ratio

5.97

EPS

$-1474.40

Revenue Growth

+0.2%

Employees

How IVF Compares to Peers

IVF has the fastest revenue growth among competitors

IVF is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 1

Margin Rank

N/A

of 1

Growth Rank

of 2

Size Rank

of 2

Company	Market Cap	P/E	Growth	Margin	Compare
IVF(This stock)	$15.18M	N/A	0%	0.0%	-
AMZNAmazon Com	$2.68T	34.7	0%	0.1%	vs AMZN

Invo Fertility Inc Company Information

Headquarters: Florida; U.S.A
Website: www.invobioscience.com
Sector: Health Care
Industry: Health Care Providers & Services

Data Updated: April 16, 2026 at 5:26 PM EDT

Ready to invest in IVF?

Commission-free trading available. Affiliate links.

IVF Lician Score

10% confidence

5.0/10

Neutral

IVF has a Lician Score of 5/10 (Average). Areas of concern: Growth.

value

5.0

growth

3.0

quality

5.0

momentum

5.0

safety

5.0

The Lician Score is a comprehensive 1-10 rating that evaluates IVFacross five key dimensions: Value (valuation relative to sector),Growth (revenue and earnings trajectory),Quality (profitability and balance sheet strength),Momentum (price trends and analyst sentiment), andSafety (volatility and risk metrics).

IVF Financial Snowflake

5-axis analysis across key investment dimensions

4.6/10

Neutral

5.0

Value

Valuation vs. sector peers

3.0

Growth

Revenue & earnings trajectory

5.0

Quality

Profitability & moat strength

5.0

Momentum

Price trends & analyst sentiment

5.0

Safety

Financial stability & risk

Upcoming Events for IVF

Dashboard

Enter a ticker to analyze